Awful News for AHF: 3 Discoveries Can Revolutionize How We Fight HIV

Mar 11, 2014
AHF
0 0
ahf

For AIDS Healthcare Foundation’s in-house latex fetishist, Michael Weinstein, condoms and costly post-infection medications are the ONLY way to deal with HIV/AIDS. He opposes Truvada / pre-exposure prophylaxis, known as ‘PrEP’ (“There truly is ‘no magic pill’ when it comes to HIV prevention.”). He even opposes government funding of research to find a vaccine.

Of course, AHF sells AIDS meds through its pharmacies — so a world without HIV/AIDS would seriously hurt his bottom line — but for Weinstein, whose organization manufactures TWO brands of condoms — LOVE and ICON — condom use is an end in itself. “People will stop using condoms if they’re taking this [PrEP] medication,” he bleats.

Now, three recent discoveries may bring us closer to the day when Weinstein and his fellow AIDS profiteers are out of a job…

 

A series of new discoveries made public last week could have significant implications for the treatment of HIV and new strategies for how to prevent its spread. Indeed, they signify a growing shift in how society understands the virus itself.

1. People With Undetectable Viral Loads Do Not Transmit The Virus

There is still no cure for HIV, but treatment methods have improved to the point that many people living with the virus are able to use antiretroviral therapy (ART) medication to reduce their viral load to “undetectable” levels. This means that an individual’s viral load is being maintained at a level that a viral load test is not able to measure.

A new study (“The PARTNER study“) suggests that it’s nearly impossible for people with undetectable viral loads to infect others with HIV through either vaginal or anal sex. The study followed nearly 900 couples who were serodiscordant (one partner was HIV positive and one was HIV negative) and undetectable and who were regularly having sex without condoms. After an estimated 16,400 occasions in which the same-sex male couples had sex and 14,000 in which the different-sex couples had sex, there was not one incidence of transmission.

There were some people in the study who became HIV positive, but genetic testing proved in every case that the virus came from someone other than the partner in the study. Likewise, the fact that no transmission occurred does not mean that transmission is absolutely impossible. Using statistical analysis, researchers estimate that the chances of transmission are about 2 percent for vaginal sex with ejaculation, 2.5 percent for receptive anal sex (in which the negative partner is bottoming), and 4 percent for receptive anal sex with ejaculation…but the researchers say the true likelihood is probably much nearer to zero than this.

This speaks to the importance of a “treatment as prevention” strategy that encourages testing and treatment. People who find out that they are HIV positive can use medication to manage their viral load and minimize — if not virtually eliminate — the risk of transmission to others.

2. Gene Modification Could Possibly Present A New HIV Treatment Option

The initial results of a study from the National Institute of Allergy and Infection Diseases find that gene modification could be safely used to help HIV positive individuals control their viral loads. In the study, individuals who were controlling their viral loads with medication volunteered to allow their T-cells to be collected and genetically mutated to be resistant to HIV infection. The cells were then replicated and infused back into the patients.

A graphic representation of the CCR5 protien. Source: Wikipedia

A graphic representation of the CCR5 protien. Source: Wikipedia

The patients then stopped their antiretroviral therapy for 8-12 weeks to assess whether the modified cells would maintain their resistance, and they did. In most of the patients, only about a fifth of their genes were mutated in the experiment, but one volunteer agreed to have half of his mutated, and after 12 weeks without ART, that individual’s viral load remained undetectable.

This is only a preliminary study, but one with promising results. Genetic modification could help individuals who are HIV positive use their own cells to resist the spread of the virus in their bodies — and thereby to others as well. This could reduce the demand for ART and help expand access to treatment options.

3. A Monthly Shot Could Held Protect People From HIV Infection

Though condoms (M/F) are the only prevention method that has the potential to literally block exposure to HIV, they are not the only method of preventing infection and not necessarily the most statistically effective. Research has shown that if HIV-negative individuals take a regiment of medication that was originally designed for treating HIV, they can drastically reduce their risk of infection — by up to 99 percent according to one study. This is known as pre-exposure prophylaxis, or PrEP.

PrEP’s effectiveness is independent of condom usage, meaning that both are part of a toolkit to reduce HIV infection. Some insurance companies are already covering PrEP, because it’s cheaper for them to prevent HIV than to treat it. PrEP’s effectiveness, however, relies upon individuals taking it every day, even when they are not sexually active, and it is not without side effects, such as nausea. A new study from the Centers for Disease Control and Prevention (CDC) shows promise that the same preventative effect could soon be achieved through a shot that individuals only have to receive monthly — or maybe even only every three months.

The study was conducted on a small group of macaque monkeys, who were given the shot once every four weeks, but who were exposed to a human-monkey version of HIV twice a week during the 11 week run of the experiment. (Editor’s note: Care2 does not endorse animal testing and believes there are viable alternatives to medical research that do not involve the testing or killing of animals.) All of the monkeys who received the placebo contracted the virus, but none of the monkeys who received the drug did. A second study tested to see just how long a single shot of the drug might last, and found that the dosage could be increased to protect the monkeys from infection for about 10 weeks on average.

Should such a treatment ever become available for human usage, individuals might more reliably follow through on a shot every few months instead of a daily pill, increasing the likelihood that they will protect themselves from infection. Testing is already underway to see if the same drug can be used as a treatment method for people who are HIV positive.

The growing discoveries about HIV present new opportunities for individuals who are both positive and negative to take steps to reduce the risk of infection. Still, boundaries remain that stigmatize people with HIV and discourage testing, such as laws that criminalize transmission of the virus. Testing, itself, has been found to help reduce the risk of transmission, and the results of these studies will allow individuals to make better informed decisions about how to use their test results to continue reducing that risk.

This post originally appeared on ThinkProgress

Awful News for AHF: 3 Discoveries Can Revolutionize How We Fight HIV

Latex fetishist and bully, Michael Weinstein of AHF

0 0 vote
Article Rating
Spread the love
Comments
Subscribe
Notify of
guest

This site uses Akismet to reduce spam. Learn how your comment data is processed.

5 Comments
Oldest
Newest Most Voted
Inline Feedbacks
View all comments
Ernest Greene
Ernest Greene
6 years ago

It’s been a tough week for AHF all the way around. It’s sad to think that meds intended to reduce the risk of HIV transmission wouldn’t enjoy the enthusiastic support of the world’s largest HIV health organization. Just yesterday, a doctor I won’t name confirmed something else told me by another doctor I won’t name: they used to work for AHF and though the clinical services AHF provides to clients are still first-rate (unlike Weinstein I believe in giving credit where due), both quit working with AHF because of what one called “the funny way they play around with the… Read more »

Deep Throat
Deep Throat
6 years ago
Reply to  Ernest Greene
Ernest Greene
Ernest Greene
6 years ago
Reply to  Deep Throat

Actually, AHF’s thievery was chump change back then. Their most recent required public audit claims nearly $15 million in non-itemized deductions. They don’t have paperwork for them and don’t care to describe them in any way, but assure the government that all that money was legitimately spent on AHF’s non-profit public service activities. Yeah, right. Try that on your 1040 and see what happens. I believe the usual term for money of unknown origins used for unstated purposes by organizations engaged in electoral politics is “slush fund.” And I doubt you’d have to go as far as the Caymans to… Read more »

trackback

[…] The FDA approved Truvada in 2012.  It is the only PrEP pill that has been shown to prevent 99% of HIV transmissions when taken as directed. […]

trackback
Petition Asks For Resignation of AHF President Michael Weinstein #removeWeinstein
6 years ago

[…] The FDA approved Truvada in 2012.  It is the only PrEP pill that has been shown to prevent 99% of HIV transmissions when taken as directed. […]

TrafficHolder.com - Buy & Sell Adult Traffic
5
0
Would love your thoughts, please comment.x
()
x